Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Stanley Black & Decker, Inc. — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B), while Stanley Black & Decker, Inc. trades at $89.66 (market cap $13.34B). The key difference: Stanley Black & Decker, Inc. is far larger — about 5.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Stanley Black & Decker, Inc. pays a 3.8% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | SWK | |
|---|---|---|
Market Cap | $2.27B | $13.34B |
Volume | 4,179,659 | 1,609,355 |
Sector | Health | Industrials |
52-Week High | $15.46 | $104.00 |
52-Week Low | $1.39 | $62.12 |
Enterprise Value | $2.14B | $17.50B |
Typical Hold Time | — | 62 Days |
Dividend Yield | — | 3.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stanley Black & Decker (SWK) trades at $88.31, down 1.87% with bearish technical signals. The company shows improving fundamentals with three consecutive quarterly EPS beats and projected 2026 net margin expansion to 4.06%. Recent product launches and margin improvement initiatives under CEO Chris Nelson provide positive catalysts. Valuation appears reasonable with P/E of 21.59 and P/S of 0.88.
SWK offers value with improving profitability and dividend stability, though technical weakness and competitive pressures present near-term risks. Analyst consensus at $93.00 suggests 5.3% upside potential. The stock's recovery depends on successful execution of margin improvement plans and sustained demand in industrial and automotive markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
